ClinicalTrialsFinder

Cytokine Release Syndrome Clinical Trials in Seattle, Washington

1 recruitingSeattle, Washington

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy

Cytokine Release Syndrome
CytoAgents, Inc.54 enrolled6 locationsNCT05905328